Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 3 1 2019
medline: 19 6 2020
entrez: 3 1 2019
Statut: ppublish

Résumé

Adrenal venous sampling (AVS) is essential for identifying a surgically curable form of primary aldosteronism. Adrenocorticotropic hormone (ACTH) infusion or bolus has been reported to improve the success rate of AVS, although the effects on lateralization and its outcomes in unilateral primary aldosteronism are unclear. The success rate and lateralization indices were examined in a cohort of 2197 Japanese patients with primary aldosteronism from 28 centres who underwent AVS. Outcomes were analysed in 267 patients with aldosterone-producing adenomas (APAs). ACTH loading during AVS improved the success rate from 67 to 89%, while lateralization indices decreased from 62 to 28%. Bolus, bolus along with continuous infusion or continuous infusion of ACTH did not affect both indices. The absence of clinical success (i.e. unchanged or increased blood pressure) was 33% and absence of biochemical success (persistent hypokalaemia or persistently raised aldosterone-to-renin ratio, or both) was 15%. The clinical and biochemical success rates did not differ between the three groups [lateralization index >2 in basal condition (LIb) and lateralization index >4 after ACTH loading (lateralization indices), and LIb >2 + lateralization indices<4, LIb<2+lateralization indices>4]. The three groups (LIb>4+lateralization indices>4, LIb>4+lateralization indices<4 and LIb<4+lateralization indices>4) did not show any significant differences of clinical and biochemical outcome. ACTH loading during AVS improved the success rate but decreased laterality. ACTH did not affect the clinical and biochemical outcomes in APA patients. These data showed that the use of ACTH during AVS was helpful for improving the success rate, but did not contribute to better outcomes.

Sections du résumé

BACKGROUND
Adrenal venous sampling (AVS) is essential for identifying a surgically curable form of primary aldosteronism. Adrenocorticotropic hormone (ACTH) infusion or bolus has been reported to improve the success rate of AVS, although the effects on lateralization and its outcomes in unilateral primary aldosteronism are unclear.
METHODS
The success rate and lateralization indices were examined in a cohort of 2197 Japanese patients with primary aldosteronism from 28 centres who underwent AVS. Outcomes were analysed in 267 patients with aldosterone-producing adenomas (APAs).
RESULTS
ACTH loading during AVS improved the success rate from 67 to 89%, while lateralization indices decreased from 62 to 28%. Bolus, bolus along with continuous infusion or continuous infusion of ACTH did not affect both indices. The absence of clinical success (i.e. unchanged or increased blood pressure) was 33% and absence of biochemical success (persistent hypokalaemia or persistently raised aldosterone-to-renin ratio, or both) was 15%. The clinical and biochemical success rates did not differ between the three groups [lateralization index >2 in basal condition (LIb) and lateralization index >4 after ACTH loading (lateralization indices), and LIb >2 + lateralization indices<4, LIb<2+lateralization indices>4]. The three groups (LIb>4+lateralization indices>4, LIb>4+lateralization indices<4 and LIb<4+lateralization indices>4) did not show any significant differences of clinical and biochemical outcome.
CONCLUSION
ACTH loading during AVS improved the success rate but decreased laterality. ACTH did not affect the clinical and biochemical outcomes in APA patients. These data showed that the use of ACTH during AVS was helpful for improving the success rate, but did not contribute to better outcomes.

Identifiants

pubmed: 30601318
doi: 10.1097/HJH.0000000000001964
doi:

Substances chimiques

Hormones 0
Aldosterone 4964P6T9RB
Adrenocorticotropic Hormone 9002-60-2
Renin EC 3.4.23.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1077-1082

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Yoshiyu Takeda (Y)

Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa.

Hironobu Umakoshi (H)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto.

Yoshimichi Takeda (Y)

Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa.

Takashi Yoneda (T)

Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa.

Isao Kurihara (I)

Department of Endocrinology, Metabolism and Nephrology, School of Medicine Keio University, Tokyo.

Takuyuki Katabami (T)

Division of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine Yokohama City Seibu Hospital.

Takamasa Ichijo (T)

Department of Endocrinology and Metabolism, Saiseikai, Yokohamashi Tobu Hospital, Yokohama.

Norio Wada (N)

Department of Diabetes and Endocrinology, Sapporo City General Hospital, Sapporo.

Takanobu Yoshimoto (T)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo.

Yoshihiro Ogawa (Y)

Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo.

Junji Kawashima (J)

Department of Metabolic Medicine, Faculty of Life Science, Kumamoto University, Kumamoto University, Kumamoto.

Masakatsu Sone (M)

Department of Diabetes, Endocrinology and Nutrition Kyoto University, Kyoto.

Katsutoshi Takahashi (K)

Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo.

Minemori Watanabe (M)

Department of Endocrinology and Diabetes, Okazaki City Hospital, Okazaki.

Yuichi Matsuda (Y)

Department of Cardiology, Sanda City Hospital, Sanda.

Hiroki Kobayashi (H)

Division of Nephrology, Hypertension and Endocrinology, Nihon University School of Medicine, Tokyo.

Hirotaka Shibata (H)

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu.

Kohei Kamemura (K)

Department of Cardiology, Akashi Medical Center, Akashi.

Michio Otsuki (M)

Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka.

Yuichi Fujii (Y)

Department of Cardiology, JR Hiroshima Hospital, Hiroshima.

Koichi Yamamto (K)

Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka.

Atsushi Ogo (A)

Clinical Research Institute, National Hospital Organization Kyusyu Medical Center.

Toshihiko Yanase (T)

Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka.

Tomoko Suzuki (T)

Department of Public Health, School of Medicine, International University of Health and Welfare, Narita, Japan.

Mitsuhide Naruse (M)

Department of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH